Aquestive Therapeutics, Inc. (AQST) ownership: Top institutional holder: Bratton Capital Management, L.P. ($40.72M). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9810958.00 | $40.72M | 2026-03-31 |
| VANGUARD GROUP INC | 5892334.00 | $38.06M | 2025-12-31 |
| BlackRock, Inc. | 7509071.00 | $31.16M | 2026-03-31 |
| RTW INVESTMENTS, LP | 7426471.00 | $30.82M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4443698.00 | $18.44M | 2026-03-31 |
| EcoR1 Capital, LLC | 2625000.00 | $16.96M | 2025-12-31 |
| Arete Wealth Advisors, LLC | 121485.00 | $14.12M | 2026-03-31 |
| FEDERATED HERMES, INC. | 2940339.00 | $12.20M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-05-18 |
Back to AQST overview · AQST earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.